Measuring minimum inhibitory concentrations in mycobacteria

Methods in Molecular Biology

Volumn 465, Issue , 2008, Pages 173-187

  Sirgel, Frederick A ^a   Wiid, Ian J F ^a   Van Helden, Paul D ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Agar proportion; Antimicrobial agents; MICs; Mycobacterium tuberculosis; Susceptibility testing

Indexed keywords

BACILLI (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

TUBERCULOSTATIC AGENT;

ARTICLE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSTRUMENTATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 77957072016     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-207-6_11     Document Type: Article

References (29)

1. Hawkins JE. Drug susceptibility testing. In Kubica GP, Wayne LG, eds. TheMycobacteria. A Sourcebook. Part A. Marcel Dekker Inc, New York and Basel, 1984:177-193.
2. Heifets LB. Introduction: Drug susceptibility tests and the clinical outcome of chemotherapy. In: Heifets LB, ed. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Inc., Boca Raton, FL, 1991:1-11.
3. National Committee for Clinical Laboratory Standards. Susceptibility testing of Mycobacteria, Norcardiae, and Other Aerobic Actinomycetes; Approved Standard. NCCLS Document M24-A. NCCLS, Wayne, PA, 2003;23(18):1-71.
4. Chan ED, Iseman MD. Current medical treatment for tuberculosis. BMJ 2002;325:1282-1286. (Pubitemid 35430589)
5. Heginbothom ML. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment. Int J Tuberc Lung Dis 2001;5(6):538-545.
6. Heifets L, Desmond E. Clinical mycobacteriology (tuberculosis) laboratory: services and methods in tuberculosis and the tubercle bacillus. In: Cole ST, Eisenach K.D, McMurray DN, Jacobs (Jr) eds. ASM Press, Washington, DC, 2005:49-69.
7. Mitchison DA. Drug resistance in tuberculosis. Eur Respir J 2005;25:376-379. (Pubitemid 40246541)
8. Dickinson JM, Mitchison DA. In vitro activity of new rifamycins against rifampinresistant M. tuberculosis and MAIS-complex mycobacteria. Tubercle 1987;68: 177-182.
9. MacGowan AP, Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother 2001;48(Suppl S1):17-28.
10. Mueller M, de la Pena A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Kill curves versus MIC. Antimicrob Agents Chemother 2004;48(2):369-377. (Pubitemid 38141689)
11. Siddiqi SH. BACTEC 460 TB system. Product and procedure manual, revision D. Becton Dickinson Microbiology Systems, Sparks, MD, 1995.
12. Heifets LB. Drug susceptibility tests in the management of chemotherapy of tuberculosis. In: Heifets LB, ed. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Inc., Boca Raton, FL, 1991:89-121.
13. Bemer P, Bodmer T, Munzinger J, Perrin M, Vincent V, Drugeon H. Multicenter evaluation of the MB/BACT System for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2004;42(3):1030-1034. (Pubitemid 38332821)
14. Chew WK, Lasaitis RM, Schio FA, Gilbert GL. Clinical evaluation of the Mycobacteria Growth Indicator Tube (MGIT) compared with radiometric (Bactec) and solid media for isolation of Mycobacterium species. J Med Microbiol 1998;47:821-827. (Pubitemid 28401548)
15. Bergmann JS, Woods GL. Evaluation of the ESP Culture System II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs. J Clin Microbiol 1998;36(10):2940-2943. (Pubitemid 28429418)
16. Woods GL, Fish G, Plaunt M, Murphy T. Clinical evaluation of Difco ESP culture system II for growth and detection of mycobacteria. J Clin Microbiol 1997;35(1):121-124. (Pubitemid 26422639)
17. Somoskövi A, Magyar P. Comparison of theMycobacteria Growth Indicator Tube with MB Redox, Löwenstein-Jensen, andMiddlebrook 7H11 media for recovery of mycobacteria in clinical specimens. J Clin Microbiol 1999;37(5):1366-1369. (Pubitemid 29187801)
18. Brunello F, Fontana R. Reliability of the MB/BACT system for testing susceptibility of Mycobacterium tuberculosis complex strains to anti-tuberculosis drugs. J Clin Microbiol 2000;38:872-873. (Pubitemid 30082699)
19. Heifets, LB. Drug susceptibility testing. In: Heifets LB (guest ed.), ClauserGed. Clinics in Laboratory Medicine, vol 16 (3). W.B. Saunders, Philadelphia, 1996:641-656. (Pubitemid 26278079)
20. Dickinson JM, Allen BW, Mitchison DA. Slide culture sensitivity tests. Tubercle 1989;70:115-121. (Pubitemid 19143966)
21. Welch DF, Guruswamy AP, Sides SJ, Shaw CH, Gilchrist MJ. Timely culture for mycobacteria which utilizes a microcolony method. J Clin Microbiol 1993;31(8):2178-2184. (Pubitemid 23210515)
22. Mejia GI, Castrillon L, Trujillo H, Robledo JA. Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 1999;3(2):138-142. (Pubitemid 29151817)
23. Park WG, Bishai R, Chaisson E, Dorman SE. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 2002;40(12):4750-4752. (Pubitemid 35434981)
24. Wanger A, Mills K. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampicin, and streptomycin by using Etest. J Clin Microbiol 1996;34(7):1672-1676. (Pubitemid 26190395)
25. Nilsson LE, Hoffner SE, Ansehehn S. Rapid susceptibility testing of M. tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother 1988;32:1208-1212.
26. Jacobs WR Jr, Barletta RG, Udani R, Chan J, Kalkut G, Sosne G, Kieser T, Sarkis GJ, Hatfull GF, Bloom BR. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993;260:819-822. (Pubitemid 23167613)
27. Albert H, Trollip A, Seaman T, Mole RJ. Simple, phage based (FastPlaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004;8(9):1114-1119. (Pubitemid 39201258)
28. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol 1998;36(2):362-366. (Pubitemid 28060296)
29. Leite CQF, Beretta ALRZ, Anno IS, Telles MAS. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility. J Antimicrob Chemother 2003;52:796-800.